Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 10 mg)
Medis Pharma Pty Ltd
rizatriptan benzoate
Tablet, orally disintegrating
Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; aspartame; calcium silicate; magnesium stearate; crospovidone; Flavour
Oral
2, 6, 3
(S4) Prescription Only Medicine
NOA is indicated for the acute treatment of migraine attacks with or without aura.
Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 5" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2015-02-19